Cargando…
An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation
BACKGROUND: Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and mortality. Circumferential pulmonary vein ablation (CPVA) is an effective rhythm control strategy, however, recurrence is an important factor influencing treatment decisions. HYPOTHESIS:...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571557/ https://www.ncbi.nlm.nih.gov/pubmed/34378199 http://dx.doi.org/10.1002/clc.23712 |
_version_ | 1784595047452246016 |
---|---|
author | Miao, Yuxia Xu, Min Zhang, Chunxu Liu, Huannian Shao, Xiaoliang Wang, Yuetao Yang, Junhua |
author_facet | Miao, Yuxia Xu, Min Zhang, Chunxu Liu, Huannian Shao, Xiaoliang Wang, Yuetao Yang, Junhua |
author_sort | Miao, Yuxia |
collection | PubMed |
description | BACKGROUND: Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and mortality. Circumferential pulmonary vein ablation (CPVA) is an effective rhythm control strategy, however, recurrence is an important factor influencing treatment decisions. HYPOTHESIS: To develop a predictive model based on left atrial (LA) structure and function, and evaluate its efficiency in predicting the recurrence of AF after CPVA. METHODS: Patients with paroxysmal AF who underwent CPVA were enrolled in this study and randomly divided into a development set and a validation set. The clinical and echocardiographic data of each patient were collected. In the development set, a least absolute shrinkage and selection operator (LASSO) regression was used to establish a LA ultrasound feature. By combining that LA ultrasound feature with independent clinical risk factors, we established an echocardiographic model using multivariate logistic regression and plotted the corresponding nomogram. RESULTS: The LA ultrasound feature established by LASSO regression included nine echocardiographic indicators related to LA structure and function. It also exhibited good predictive ability in both the development set and the validation set (AUC:0.944, 95%CI: 0.910–0.978; AUC:0.878, 95%CI: 0.816–0.942). Logistic regression analysis indicated that LA ultrasound feature and AF duration were independent predictors for AF recurrence. The combined model including LA ultrasound feature and AF duration also showed good discriminability in both the development set (AUC: 0.950, 95% CI:0.914–0.985) and the validation set (AUC: 0.890, 95% CI: 0.831–0.949). The calibration curve showed good agreement between the predicted value and observed value. CONCLUSIONS: Our model that is based on LA structure and function measured by echocardiography is a useful non‐invasive preoperative tool, which exhibits good accuracy in predicting the recurrence of AF after CPVA. |
format | Online Article Text |
id | pubmed-8571557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85715572021-11-10 An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation Miao, Yuxia Xu, Min Zhang, Chunxu Liu, Huannian Shao, Xiaoliang Wang, Yuetao Yang, Junhua Clin Cardiol Clinical Investigations BACKGROUND: Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and mortality. Circumferential pulmonary vein ablation (CPVA) is an effective rhythm control strategy, however, recurrence is an important factor influencing treatment decisions. HYPOTHESIS: To develop a predictive model based on left atrial (LA) structure and function, and evaluate its efficiency in predicting the recurrence of AF after CPVA. METHODS: Patients with paroxysmal AF who underwent CPVA were enrolled in this study and randomly divided into a development set and a validation set. The clinical and echocardiographic data of each patient were collected. In the development set, a least absolute shrinkage and selection operator (LASSO) regression was used to establish a LA ultrasound feature. By combining that LA ultrasound feature with independent clinical risk factors, we established an echocardiographic model using multivariate logistic regression and plotted the corresponding nomogram. RESULTS: The LA ultrasound feature established by LASSO regression included nine echocardiographic indicators related to LA structure and function. It also exhibited good predictive ability in both the development set and the validation set (AUC:0.944, 95%CI: 0.910–0.978; AUC:0.878, 95%CI: 0.816–0.942). Logistic regression analysis indicated that LA ultrasound feature and AF duration were independent predictors for AF recurrence. The combined model including LA ultrasound feature and AF duration also showed good discriminability in both the development set (AUC: 0.950, 95% CI:0.914–0.985) and the validation set (AUC: 0.890, 95% CI: 0.831–0.949). The calibration curve showed good agreement between the predicted value and observed value. CONCLUSIONS: Our model that is based on LA structure and function measured by echocardiography is a useful non‐invasive preoperative tool, which exhibits good accuracy in predicting the recurrence of AF after CPVA. Wiley Periodicals, Inc. 2021-08-11 /pmc/articles/PMC8571557/ /pubmed/34378199 http://dx.doi.org/10.1002/clc.23712 Text en © 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Miao, Yuxia Xu, Min Zhang, Chunxu Liu, Huannian Shao, Xiaoliang Wang, Yuetao Yang, Junhua An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title | An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title_full | An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title_fullStr | An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title_full_unstemmed | An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title_short | An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
title_sort | echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571557/ https://www.ncbi.nlm.nih.gov/pubmed/34378199 http://dx.doi.org/10.1002/clc.23712 |
work_keys_str_mv | AT miaoyuxia anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT xumin anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT zhangchunxu anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT liuhuannian anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT shaoxiaoliang anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT wangyuetao anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT yangjunhua anechocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT miaoyuxia echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT xumin echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT zhangchunxu echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT liuhuannian echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT shaoxiaoliang echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT wangyuetao echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation AT yangjunhua echocardiographicmodelforpredictingtherecurrenceofparoxysmalatrialfibrillationaftercircumferentialpulmonaryveinablation |